The AstraZeneca COVID-19 vaccine is suspected of being linked to a small number of deep vein thrombosis cases, which led several countries to suspend AstraZeneca injections. Researchers explored a hypothesis that this pause, even if short, could cause additional deaths from the faster spread of COVID-19. They report using an epidemiological model and statistical analysis to estimate excess deaths resulting from suspending AstraZeneca vaccinations and those potentially linked to DVT-adverse events in France and Italy.